BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10976008)

  • 41. Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes.
    Igaz P; Tóth S; Rose-John S; Madurka I; Fejér G; Szalai C; Falus A
    Cytokine; 1998 Aug; 10(8):620-6. PubMed ID: 9722935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of thalidomide on Bcl2 expression and proangiogenic cytokine levels in short-term culture of peripheral blood and bone marrow mononuclear cells of multiple myeloma patients.
    Dmoszyńska A; Roliński J; Bojarska-Junak A; Mańko J; Jawniak D; Walter-Croneck A; Soroka-Wojtaszko M; Hus M
    Pol J Pharmacol; 2001; 53(6):709-13. PubMed ID: 11985351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
    Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS
    J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Down-regulation of expression of interleukin-6 and its receptor results in growth inhibition of MCF-7 breast cancer cells.
    Jiang XP; Yang DC; Elliott RL; Head JF
    Anticancer Res; 2011 Sep; 31(9):2899-906. PubMed ID: 21868536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells.
    Erices A; Conget P; Rojas C; Minguell JJ
    Exp Cell Res; 2002 Oct; 280(1):24-32. PubMed ID: 12372336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
    Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP
    Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25high regulatory T cells.
    Oberg HH; Wesch D; Grüssel S; Rose-John S; Kabelitz D
    Int Immunol; 2006 Apr; 18(4):555-63. PubMed ID: 16540526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage.
    Sui Y; Lee JH; DiMicco MA; Vanderploeg EJ; Blake SM; Hung HH; Plaas AH; James IE; Song XY; Lark MW; Grodzinsky AJ
    Arthritis Rheum; 2009 Oct; 60(10):2985-96. PubMed ID: 19790045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA.
    Oh JW; Revel M; Chebath J
    Cytokine; 1996 May; 8(5):401-9. PubMed ID: 8726669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model.
    Chabaud M; Miossec P
    Arthritis Rheum; 2001 Jun; 44(6):1293-303. PubMed ID: 11407688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Influence of thalidomide on bone marrow microenvironment in refractory and relapsed multiple myeloma].
    Li J; Luo SK; Hong WD; Zhou ZH; Zou WY
    Ai Zheng; 2003 Apr; 22(4):346-9. PubMed ID: 12703985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains.
    Schwabe M; Brini AT; Bosco MC; Rubboli F; Egawa M; Zhao J; Princler GL; Kung HF
    J Clin Invest; 1994 Dec; 94(6):2317-25. PubMed ID: 7989587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3.
    Takizawa T; Yanagisawa M; Ochiai W; Yasukawa K; Ishiguro T; Nakashima K; Taga T
    Cytokine; 2001 Mar; 13(5):272-9. PubMed ID: 11243705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
    Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
    Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway.
    Liu XH; Kirschenbaum A; Lu M; Yao S; Klausner A; Preston C; Holland JF; Levine AC
    Biochem Biophys Res Commun; 2002 Jan; 290(1):249-55. PubMed ID: 11779161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells.
    Rawstron AC; Fenton JA; Ashcroft J; English A; Jones RA; Richards SJ; Pratt G; Owen R; Davies FE; Child JA; Jack AS; Morgan G
    Blood; 2000 Dec; 96(12):3880-6. PubMed ID: 11090073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormal regulation of soluble and anchored IL-6 receptor in monocytes from patients with essential thrombocythemia.
    Goette NP; Lev PR; Heller PG; Glembotsky AC; Chazarreta CD; Salim JP; Molinas FC; Marta RF
    Exp Hematol; 2010 Oct; 38(10):868-876.e1. PubMed ID: 20600579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts.
    Vermes C; Jacobs JJ; Zhang J; Firneisz G; Roebuck KA; Glant TT
    J Biol Chem; 2002 May; 277(19):16879-87. PubMed ID: 11884403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of soluble interleukin-6 receptor on interleukin-6 synthesis in human skin fibroblasts.
    Cichy J; Rose-John S; Pryjma J; Travis J
    Biochem Biophys Res Commun; 1996 Oct; 227(2):318-21. PubMed ID: 8878515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.